Posted by Michael Wonder on 07 May 2017
New NICE criteria for drug access
1 May 2017 - An overhaul of NHS drug access in England by NICE and NHS England, which for the first time includes affordability criteria in addition to cost-effectiveness, will place an additional hurdle on access to cancer drugs.
The new criteria, to be introduced by NICE and NHS England on April 1, 2017, could lead to England falling further behind other European countries in drug availability, endanger clinical trials, and jeopardise the industrial standing of life sciences post-Brexit.
